companydata.dkcompanydata.dk

New Cardiolab ApS: Financial statements 2025

CVR: 36895705

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

New Cardiolab ApS (CVR 36895705) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,878,462 and a net result of DKK 76,064 compared with DKK 1,099,197 the year before. That is an increase of 26.6% compared with the year before. Equity in the 2025 report amounted to DKK 300,501. The solvency ratio was 14.2%. The company had 6 employees in the financial year.

Gross Profit
DKK 1,878,462
Profit/Loss
DKK 76,064
Equity
DKK 300,501
Total Assets
DKK 2,120,403
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1.9 mio.76 t.301 t.6
2024-1.5 mio.1.1 mio.224 t.4
2023-1.1 mio.-379 t.-875 t.5
2022-1.2 mio.180 t.-496 t.5
2021-195 t.516 t.-675 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is New Cardiolab ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

New Cardiolab ApS: The 2024 annual report is outMay 1, 2025

New Cardiolab ApS has published its annual report for 2024. Gross profit came to DKK 1,483,747, and the net result was DKK 1,099,197.

About New Cardiolab ApS

New Cardiolab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2015. The company is registered under the industry Speciallægers aktiviteter. The management consists of Janet Alsø and Susan Alsø. The company is owned by Susan Alsø Holding ApS and Janet Alsø Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 1,878,462 and a net result of DKK 76,064 compared with DKK 1,099,197 the year before. Equity in the 2025 report amounted to DKK 300,501.

Source: annual report 2025, Danish Business Authority